Related Experiment Video
Updated: Apr 15, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and
Nehal S Parikh1, Scott C Howard2, Guillermo Chantada3
1Department of Pediatrics, Division of Hematology-Oncology, Connecticut Children's Medical Center, Hartford, Connecticut.
Abstract:
Neuroblastoma is the most common extracranial solid tumor in childhood in high-income countries (HIC), where consistent treatment approaches based on clinical and tumor biological risk stratification have steadily improved outcomes. However, in low- and middle- income countries (LMIC), suboptimal diagnosis, risk stratification, and treatment may occur due to limited resources and unavailable infrastructure. The clinical practice guidelines outlined in this manuscript are based on current published evidence and expert opinions. Standard risk stratification and treatment explicitly adapted to graduated resource settings can improve outcomes for children with neuroblastoma by reducing preventable toxic death and relapse.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers

